Cutler Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2586 |
|
|
2022
Q2 | – | Sell |
-420
| Closed | -$18K | – | 2603 |
|
|
2022
Q1 | $18K | Sell |
420
-680
| -62% | -$29.1K | ﹤0.01% | 1397 |
|
|
2021
Q4 | $55K | Buy |
1,100
+100
| +10% | +$5K | ﹤0.01% | 1162 |
|
|
2021
Q3 | $63K | Hold |
1,000
| – | – | ﹤0.01% | 1139 |
|
|
2021
Q2 | $71K | Hold |
1,000
| – | – | ﹤0.01% | 1119 |
|
|
2021
Q1 | $73K | Hold |
1,000
| – | – | ﹤0.01% | 1015 |
|
|
2020
Q4 | $73K | Sell |
1,000
-100
| -9% | -$7.3K | ﹤0.01% | 885 |
|
|
2020
Q3 | $60K | Hold |
1,100
| – | – | ﹤0.01% | 833 |
|
|
2020
Q2 | $73K | Sell |
1,100
-200
| -15% | -$13.3K | ﹤0.01% | 734 |
|
|
2020
Q1 | $79K | Hold |
1,300
| – | – | ﹤0.01% | 670 |
|
|
2019
Q4 | $114K | Buy |
+1,300
| New | +$114K | 0.01% | 659 |
|
|
2019
Q1 | – | Sell |
-100
| Closed | -$8K | – | 2334 |
|
|
2018
Q4 | $8K | Sell |
100
-251
| -72% | -$20.1K | ﹤0.01% | 1299 |
|
|
2018
Q3 | $34K | Hold |
351
| – | – | ﹤0.01% | 1034 |
|
|
2018
Q2 | $40K | Sell |
351
-549
| -61% | -$62.6K | ﹤0.01% | 954 |
|
|
2018
Q1 | $88K | Hold |
900
| – | – | 0.01% | 780 |
|
|
2017
Q4 | $94K | Buy |
900
+800
| +800% | +$83.6K | ﹤0.01% | 867 |
|
|
2017
Q3 | $11K | Buy |
+100
| New | +$11K | ﹤0.01% | 1880 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 3425 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3486 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3521 |
|
|
2016
Q3 | – | Sell |
-300
| Closed | -$43K | – | 3483 |
|
|
2016
Q2 | $43K | Sell |
300
-700
| -70% | -$100K | ﹤0.01% | 1451 |
|
|
2016
Q1 | $143K | Buy |
+1,000
| New | +$143K | 0.01% | 755 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3365 |
|